Study of RAD001 for Treatment of NF2-related Vestibular Schwannoma

This study is currently recruiting participants. (see Contacts and Locations)
Verified December 2012 by House Research Institute
Sponsor:
Collaborator:
Novartis Pharmaceuticals
Information provided by (Responsible Party):
Marco Giovannini, MD, PhD, House Research Institute
ClinicalTrials.gov Identifier:
NCT01345136
First received: April 21, 2011
Last updated: December 7, 2012
Last verified: December 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: January 2015
  Estimated Primary Completion Date: January 2015 (Final data collection date for primary outcome measure)